July 24, 2017 11:12 AM ET

Pharmaceuticals

Company Overview of BioCardia, Inc.

Company Overview

BioCardia, Inc., a clinical-stage regenerative medicine company, develops therapeutics for cardiovascular diseases. Its lead therapeutic candidate is the CardiAMP Cell Therapy System that is in Phase III pivotal trials for ischemic systolic heart failure. The CardiAMP Cell Therapy System comprises cell potency screening test, a point of care cell processing platform, and a biotherapeutic delivery system. The company is also developing CardiALLO Cell Therapy System, an allogeneic off the shelf mesenchymal stem cell product candidate, which is in Phase II trials used for the treatment of ischemic systolic heart failure. In addition, it offers the Helix biotherapeutic delivery system and Morph ...

125 Shoreway Road

Suite B

San Carlos, CA 94070

United States

14 Employees

Phone:

650-226-0120

Fax:

650-631-3731

Key Executives for BioCardia, Inc.

President, CEO & Director
Age: 50
Total Annual Compensation: $357.6K
Vice President of Finance
Age: 54
Total Annual Compensation: $203.8K
Vice President of Operations
Age: 51
Total Annual Compensation: $243.6K
Chief Medical Officer
Age: 49
Total Annual Compensation: $83.3K
Vice President of Quality Assurance
Age: 61
Total Annual Compensation: $246.5K
Compensation as of Fiscal Year 2016.

BioCardia, Inc. Key Developments

BioCardia, Inc., Annual General Meeting, Jun 15, 2017

BioCardia, Inc., Annual General Meeting, Jun 15, 2017, at 09:00 Pacific Standard Time. Location: Wilson Sonsini Goodrich & Rosati, P.C., 650 Page Mill Road Palo Alto, CA 94304-1050 United States Agenda: To elect two Class I directors to serve until the 2020 annual meeting of stockholders and until their successors are duly elected and qualified; to ratify the appointment of KPMG LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2017; to hold a non-binding vote on executive compensation; to hold a non-binding vote on the frequency of executive compensation votes; and to transact such other business as may properly come before the Annual Meeting or any adjournments or postponements thereof.

BioCardia, Inc. Presents at ARM's 5th Annual Cell & Gene Therapy Investor Day, Apr-27-2017 11:25 AM

BioCardia, Inc. Presents at ARM's 5th Annual Cell & Gene Therapy Investor Day, Apr-27-2017 11:25 AM. Venue: The State Room, 60 State St., Boston, MA 02109, United States. Speakers: Peter A. Altman, Chief Executive Officer, President and Director.

Biocardia, Inc. Announces CardiAMP Pivotal Heart Failure Trial Initiated at Two US Centers

BioCardia, Inc. announced the initiation of the CardiAMP Heart Failure pivotal trial, a randomized, controlled, multi-center study of up to 260 patients evaluating CardiAMP cell therapy at up to 40 clinical sites in the United States. The trial has been initiated at two world-class centers: Johns Hopkins University, under the leadership of Dr. Peter Johnston and Dr. Gary Gerstenblith, and the University of Florida at Gainesville, under the leadership of Dr. David Anderson and Dr. Carl Pepine. The CardiAMP Therapy for heart failure integrates a biomarker panel, a cell processing system for autologous bone marrow-derived cells, and a unique transendocardial delivery system. This therapy will be reviewed under the PMA regulations by the FDA’s Center for Biologics Evaluation and Research (CBER) division.

Similar Private Companies By Industry

Company Name Region
1st Order Pharmaceuticals, Inc. United States
21st Century Animal Health United States
3 Buds' Organics LLC United States
4P Therapeutics LLC United States
60° Pharmaceuticals, LLC United States

Recent Private Companies Transactions

Type
Date
Target
Private Placement
September 30, 2016
--
Merger/Acquisition
August 23, 2016
Tiger X Medical, Inc.
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
The Advertising Council, Inc. United States
Bertelsmann AG Europe
Rush University United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact BioCardia, Inc., please visit www.biocardia.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.